Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update

Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red, watery eyes, and dry cough. Treatment includes antibiotics.

The Pertussis drugs in development market research report provides comprehensive information on the therapeutics under development for pertussis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for pertussis and features dormant and discontinued projects.

What are the key targets in the pertussis pipeline products market?

The key targets in the pertussis pipeline products market are Pertussis Toxin, Diphtheria Toxin, Tetanus Toxin, Haemophilus influenzae Lipooligosaccharide, Bordetella pertussis Pertactin, Bordetella pertussis Pertussis Toxin S1 Subunit, Cells Expressing Stabilin 1, Hemagglutinin, and Toll Like Receptor 9.

Pertussis Pipeline Products Market Analysis by Targets

For more target insights, download a free report sample

What are the key mechanisms of action in the pertussis pipeline products market?

The key mechanisms of action in the pertussis pipeline products market are Bordetella pertussis Pertussis Toxin S1 Subunit Inhibitor, Cytotoxic To Cells Expressing Stabilin 1, and Pertussis Toxin Inhibitor.

Pertussis Pipeline Products Market Analysis by Mechanism of Actions

For more mechanism of actions insights, download a free report sample

What are the key routes of administration in the pertussis pipeline products market?

The key routes of administration in the pertussis pipeline products market are intramuscular, nasal, subcutaneous, oral, cutaneous, intravenous, and parenteral.

Pertussis Pipeline Products Market Analysis by Routes of Administration

For more routes of administration insights, download a free report sample

What are the different molecule types in the pertussis pipeline products market?

The different molecule types in the pertussis pipeline products market are toxoid vaccine, vaccine, inactivated vaccine, conjugate vaccine, subunit vaccine, live attenuated vaccine, monoclonal antibody, small molecule, DNA vaccine, and recombinant vector vaccine.

Pertussis Pipeline Products Market Analysis by Molecule Type

To know more about molecule types, download a free report sample

Which are the major companies in the pertussis pipeline products market?

Some of the major companies in the pertussis pipeline products market are Serum Institute of India Pvt Ltd, Beijing Minhai Biotechnology Co Ltd, CanSino Biologics Inc, AIM Vaccine Co Ltd, Biological E Ltd, GlaxoSmithKline Plc, ILiAD Biotechnologies LLC, KM Biologics Co Ltd, Olymvax Biopharmaceuticals Inc, and Suzhou Weichao Biotechnology Co Ltd.

Pertussis Pipeline Products Market Analysis by Companies

To know more about major companies, download a free report sample

Market Report Scope

Scope

• The report provides a snapshot of the global therapeutic landscape of Pertussis (Whooping Cough)
• The report reviews pipeline therapeutics for Pertussis (Whooping Cough) by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in Pertussis (Whooping Cough) therapeutics and enlists all their major and minor projects
• The report assesses Pertussis (Whooping Cough) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews the latest news related to pipeline therapeutics for Pertussis (Whooping Cough)

Reasons to Buy

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage
• Identify and understand important and diverse types of therapeutics under development for Pertussis (Whooping Cough)
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding Pertussis (Whooping Cough) pipeline depth and focus on Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from the pipeline